Lammers T - Search Results

1

Engineering Mesoscopic 3D Tumor Models with a Self-Organizing Vascularized Matrix.

De Lorenzi F, Hansen N, Theek B, Daware R, Motta A, Breuel S, Nasehi R, Baumeister J, Schöneberg J, Stojanović N, von Stillfried S, Vogt M, Müller-Newen G, Maurer J, Sofias AM, Lammers T, Fischer H, Kiessling F. De Lorenzi F, et al. Among authors: lammers t. Adv Mater. 2024 Feb;36(5):e2303196. doi: 10.1002/adma.202303196. Epub 2023 Nov 10. Adv Mater. 2024. PMID: 37865947

2

HPMA-based polymer therapeutics improve the efficacy of surgery, of radiotherapy and of chemotherapy combinations.

Lammers T, Subr V, Ulbrich K, Peschke P, Huber PE, Hennink WE, Storm G, Kiessling F. Lammers T, et al. Nanomedicine (Lond). 2010 Dec;5(10):1501-23. doi: 10.2217/nnm.10.130. Nanomedicine (Lond). 2010. PMID: 21143030

3

Theranostic nanomedicine.

Lammers T, Aime S, Hennink WE, Storm G, Kiessling F. Lammers T, et al. Acc Chem Res. 2011 Oct 18;44(10):1029-38. doi: 10.1021/ar200019c. Epub 2011 May 5. Acc Chem Res. 2011. PMID: 21545096 Review.

4

FMN-coated fluorescent iron oxide nanoparticles for RCP-mediated targeting and labeling of metabolically active cancer and endothelial cells.

Jayapaul J, Hodenius M, Arns S, Lederle W, Lammers T, Comba P, Kiessling F, Gaetjens J. Jayapaul J, et al. Among authors: lammers t. Biomaterials. 2011 Sep;32(25):5863-71. doi: 10.1016/j.biomaterials.2011.04.056. Epub 2011 May 24. Biomaterials. 2011. PMID: 21605902

5

Iron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imaging.

Liu Z, Lammers T, Ehling J, Fokong S, Bornemann J, Kiessling F, Gätjens J. Liu Z, et al. Among authors: lammers t. Biomaterials. 2011 Sep;32(26):6155-63. doi: 10.1016/j.biomaterials.2011.05.019. Epub 2011 May 31. Biomaterials. 2011. PMID: 21632103

6

Virtual elastic sphere processing enables reproducible quantification of vessel stenosis at CT and MR angiography.

Gremse F, Grouls C, Palmowski M, Lammers T, de Vries A, Grüll H, Das M, Mühlenbruch G, Akhtar S, Schober A, Kiessling F. Gremse F, et al. Among authors: lammers t. Radiology. 2011 Sep;260(3):709-17. doi: 10.1148/radiol.11110069. Epub 2011 Jul 25. Radiology. 2011. PMID: 21788527

7

Overcoming cellular multidrug resistance using classical nanomedicine formulations.

Kunjachan S, Błauż A, Möckel D, Theek B, Kiessling F, Etrych T, Ulbrich K, van Bloois L, Storm G, Bartosz G, Rychlik B, Lammers T. Kunjachan S, et al. Among authors: lammers t. Eur J Pharm Sci. 2012 Mar 12;45(4):421-8. doi: 10.1016/j.ejps.2011.08.028. Epub 2011 Sep 1. Eur J Pharm Sci. 2012. PMID: 21907796

8

Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress.

Lammers T, Kiessling F, Hennink WE, Storm G. Lammers T, et al. J Control Release. 2012 Jul 20;161(2):175-87. doi: 10.1016/j.jconrel.2011.09.063. Epub 2011 Sep 16. J Control Release. 2012. PMID: 21945285 Review.

9

Nanomedicine formulations for combination therapies.

Lammers T, Storm G, Kiessling F. Lammers T, et al. Nano Rev. 2010;1. doi: 10.3402/nano.v1i0.5705. Epub 2010 Nov 8. Nano Rev. 2010. PMID: 22110857 Free PMC article. No abstract available.

10

Theranostic systems and strategies for monitoring nanomedicine-mediated drug targeting.

Kunjachan S, Jayapaul J, Mertens ME, Storm G, Kiessling F, Lammers T. Kunjachan S, et al. Among authors: lammers t. Curr Pharm Biotechnol. 2012 Mar;13(4):609-22. doi: 10.2174/138920112799436302. Curr Pharm Biotechnol. 2012. PMID: 22214503 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

366 results

Search Page